Stockscreener 앱 받기
0.3168
4.61%
-0.0153
시간 외 거래:
.34
0.0232
+7.32%
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
Mangoceuticals Inc (MGRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mangoceuticals Inc (MGRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mangoceuticals Inc (MGRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mangoceuticals Inc (MGRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mangoceuticals Inc (MGRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mangoceuticals Inc (MGRX) Institutional Confidence - TradingKey
Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MGRX Q3 2025 Earnings: EPS Loss of -$0.69 Highlights Ongoing Operational ChallengesPerformance Review - newsline.com
MGRX Price Today: Mangoceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC
MGRX Q3 2025 Earnings: Deepening Losses Amid Pre-Revenue Development StageProfit Announcement - newsline.com
MGRX Technical Analysis & Stock Price Forecast - Intellectia AI
Number of shareholders of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView
MGRX Q3 2025 Earnings: EPS of -$0.69 Reflects Ongoing Investment; Shares Dip 2.56%Subscription Growth Report - The Legal Advocate
MGRX Stock Price, Quote & Chart | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
MGRX Q3 2025 Earnings: Narrowing Losses as Strategic Pivot Gains MomentumEarnings Miss Streak - newsline.com
MGRX Q3 2025 Earnings: EPS Surprises with -$0.69 Loss as Revenue Remains UndisclosedROA Comparison - The Legal Advocate
Mangoceuticals Inc. (MGRX) Holds Near $0.44 After Marginal Uptick — Support and Resistance TightenVolume Profile - Newser
MANGOCEUTICALS, INC. 1Q 2026: Revenue $67.9K, EPS $(0.22) — 10-Q Summary - TradingView
Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash - Stock Titan
MGRX: Net loss narrowed but liquidity and Nasdaq compliance risks persist, requiring urgent funding - TradingView
Mangoceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Mangoceuticals Delays Quarterly Filing After Audit Review - TipRanks
[NT 10-Q] MANGOCEUTICALS, INC. SEC Filing - Stock Titan
MGRX (Mangoceuticals) Q3 loss widens, but stock rallies 7% on positive outlook.Rating Upgrade - Newser
Mangoceuticals stock doubles after Texas lawsuit - MSN
Is Mangoceuticals (MGRX) stock near support |Real-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Mangoceuticals (MGRX) Stock: Market Structure (Buying Pressure) 2026-04-20Collaborative Trading Signals - Newser
Mangoceuticals (MGRX) Stock: Should You Take Exposure (Smart Money Exits) 2026-04-18Top Analyst Buy Signals - Xã Thanh Hà
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Final Week: Can Mangoceuticals Inc expand its profit marginsBull Run & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Support Test: Will Mangoceuticals Inc outperform tech stocksMarket Trend Report & Technical Pattern Based Signals - baoquankhu1.vn
Ideas Watch: Can Mangoceuticals Inc expand into new markets2026 Selloffs & Reliable Volume Spike Alerts - baoquankhu1.vn
Is Mangoceuticals (MGRX) Stock Breaking Out | Price at $0.34, Up 0.30%Ichimoku Kumo Twist - newsline.com
Aug Chart Watch: Does Mangoceuticals Inc have a sustainable dividendQuarterly Trade Review & AI Enhanced Trading Alerts - baoquankhu1.vn
Head to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX) - Defense World
Institution Moves: Will Mangoceuticals Inc benefit from seasonality2026 Big Picture & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Mangoceuticals Inc stock falls amid market weakness - Intellectia AI
Securities.io - Securities.io
Mangoceuticals, Inc. (MGRX) stock price, news, quote and history - Yahoo Finance UK
MGRX Stock Analysis: Mangoceuticals Inc down 2.19% to $0.35, wellness stock outlook - Newser
MGRX: 2025 net loss widened to $20.6M on $456K revenue, with ongoing funding and dilution risks - TradingView
Mangoceuticals, Inc. (MGRX) 2025 Annual Report – Financials, Equity, and Consulting Agreements Overview - Minichart
Mangoceuticals 10-K: Revenue $0.456M, EPS loss $(2.17) - TradingView — Track All Markets
Mangoceuticals (NASDAQ: MGRX) details 1-for-15 reverse split and $100M Solana treasury vision - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Mangoceuticals Delays Annual 10-K Yearly Filing - TipRanks
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Faraday Future Intelligent Electric shares are trading higher by around 55%; here are 20 stocks moving premarket - MSN
Penny Stocks To Watch Today – March 23rd - Defense World
Risks Report: How does Mangoceuticals Inc perform in inflationary periods2026 Patterns & Smart Money Movement Tracker - baoquankhu1.vn
1.11%
자본화:
|
볼륨(24시간):